EU body backs Novartis' Galvus, Eucreas for diabetes indications (Reuters, 21 September 2012)

24 Sept 2012


The European Medicines Agency has issued a positive opinion for new indications of two AG Novartis drugs Galvus and Eucreas in patients with type II diabetes.

Full article


Share this story